DSA引导下经皮穿刺微球囊压迫术治疗原发性三叉神经痛的临床疗效

打开文本图片集

[Abstract]Objective：Toevaluatetheclinical eficacyof percutaneousmicrobalooncompresson（PMC）guidedbyDSA in thetreatment ofprimary trigeminal neuralgia. Methods ： 30 patients with primary trigeminal neuralgia were treated withstandardized PMC.The Brisman efficacy evaluation criteria，visual analogue scale （VAS） score，Barrow Neurologic Institute（BNI）painscalegrading，postoperativecomplications，andrecurrencewereobservedatdiferenttimesaftersurgery. Results：The total effctive rate of PMC was 96.7%（29/30），among them，19 cases were cured（ 63.3% ），8 cases were significantlyimproved（26.7%），2 cases were effective （6.7%），and1 case was ineffective（ 3.3% ）.Comparedto before PMC，in 1day，monthand6monthsafterPMC，theVAscoressignificantlydcreased，Bpainscalegradingsignificantlyiroed， and the diferences were statistically significant （both P<0.05 ）.The incidence of postoperative sensory abnormalities and masticatory muscle weaknesswere relatively high，and significantly decreasedat 6 months after PMC（both P<0.05 ）．After 6monthsoffolow-up，there wereatotalof2casesofrecurrenceandnodeaths.Conclusions：PMCguidedbyDSAhasa goodtherapeuticefectontrigeminal neuralgia.Complicationscanbegraduallyrelieved，therecurrencerateis low，and it has good safety and efficacy.

[Keywords]Percutaneousmicrobalooncompresion;Angiogaphydigitalsubtraction;Trigeminalneuralgia;Therapeticefect

三叉神经痛是一种临床常见病、多发病，多为单侧头面部阵发性剧烈疼痛，多发于中老年人，严重影响患者生活质量；临床常用卡马西平和加巴喷丁等药物治疗，具有一定止疼效果，但不良反应较大，长期应用易产生耐受性[]。（剩余5000字）